This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Today, a brief rundown of news from Praxis Precision Medicines, Rezolute and Geron, as well as updates from Rhythm Pharmaceuticals and Centessa Pharmaceuticals that you may have missed. Praxis Precision Medicines on Thursday announced plans to, sometime early next year, submit an experimental seizure drug for U.S. approval. Researchers have been evaluating the ...